Covishield


Covishield has been developed by the Oxford-AstraZeneca and is being manufactured by the Serum Institute of India (SII).


Covishield has been prepared using the viral vector platform which is a totally different technology.

A chimpanzee adenovirus – ChAdOx1 – has been modified to enable it to carry the COVID-19 spike protein into the cells of humans. Well, this cold virus is basically incapable of infecting the receiver but can very well teach the immune system to prepare a mechanism against such viruses.

The exact technology was used to prepare vaccines for viruses like Ebola.

Covishield can be stored at 2-8 degrees Centigrade, which is a household refrigerator temperature. This makes both the vaccines most suited for Indian conditions as most of the vaccines here are kept at the same temperature range.

This also makes the transportation and storage of both vaccines easier.

The vaccine have shown more than satisfactory results ever since the inoculation started in India.

After injecting the vaccine, you may experience pain at the site of injection. Some people also experience side effects such as headache, joint pain, may feel like feverish. These side effects do not persist for long and generally goes within a day or two.

Efficacy after the second dose can vary from 70-90%

The interval between 1st and 2nd doses is 12-16 weeks.

People above 18 years of age can opt for this vaccine.

Covishield is more easily available.

www.rajveerhometutorial.com

Enhance your knowledge with Rajveer Home Tutorial Personalized Online Tuition and Offline Tuition*, contact us on: 8090970148/9956318228 and start your trial class right away. 

*Offline Tuition facility is provided only in Lucknow, U.P

Personalized Online Tuition is Available all over India

For more details Call/WhatsApp On: 8090970148

Comments